Intuitive doesn ’t expect any Chinese expanded quota da Vinci Sales this year
Intuitive Surgical (NSDQ:ISRG) said yesterday that despite the Chinese National Health Commission publishing a new quota expansion looking to add more surgical robots over the next two years, it does not expect to sell any systems under the new quota this year. Sunnyvale, Calif.-based Intuitive Surgical saw shares rise over 5% yesterday on the news that the Chinese Government was calling for a total of 197 endoscopic surgical instrument control systems, or surgical robots, by the end of 2020. That number includes 154 new systems, according to the government release. Shortly after the announcement, the robotic surgical...
Source: Mass Device - November 1, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Robotics Surgical Intuitive Surgical Source Type: news
Intuitive Surgical shares rise on expanded surgical robot quota in China
Intuitive Surgical (NSDQ:ISRG) shares have risen over 5% in pre-market trading after the Chinese government released a new Large-Scale Medical Equipment Configuration Plan calling for an additional 154 surgical robot systems to be deployed in the country by the end of 2020. The official release from the Chinese Government calls for a total of 197 endoscopic surgical instrument control systems, or surgical robots, by the end of 2020. That number includes an additional 154 new systems. The last time the government issued a similar quota expansion was in 2013, according to a Leerink Partner letter to investors by analyst...
Source: Mass Device - October 31, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Robotics Intuitive Surgical Source Type: news
4 Reasons Medtech Outsourcers Should Consider Cold Forming
This article covers the economic, strength, yield, and speed-to-market advantages of cold-formed components, especially compared with the capabilities of screw machining. The objective will be to provide potential new product design (NPD) engineers in outsource manufacturing environments an objective comparison from which to make informed decisions on micro-miniature component sourcing. NPD engineers rely heavily on design and manufacturing techniques learned through education, repeated application, and empirical success. Many alternate techniques are often approached with caution, particularly in medical and healthcare pr...
Source: MDDI - October 10, 2018 Category: Medical Devices Authors: Timothy Kardish Tags: Contract Manufacturing Source Type: news
Statins associated with improvement of rare lung disease
This study suggests that oral statin therapy may be a new approach for patients with autoimmune pulmonary alveolar proteinosis.AUTHORSThe study ’s co-senior authors are Dr. Elizabeth Tarling of UCLA and Dr. Bruce Trapnell of Children’s Hospital Medical Center of Cincinnati, Ohio. Other authors are listed in the journal article.JOURNALThe study was published in the journal Nature Communications. FUNDINGThe National Institutes of Health funded the research.Learn more about the cardiovascular research theme at UCLA. (Source: UCLA Newsroom: Health Sciences)
Source: UCLA Newsroom: Health Sciences - August 17, 2018 Category: Universities & Medical Training Source Type: news
Cook Medical wins FDA de novo nod for Hemospray
Cook Medical said yesterday it won FDA de novo clearance for its Hemospray endoscopic hemostat designed for treating bleeding in the gastrointestinal tract. The Hemospray product won indications from the FDA for treating non-variceal GI bleeds, the Bloomington, Ind.-based company said. Hemospray is a single-use device designed to deliver an aerosolized spray of a mineral blend to a bleeding site during endoscopic procedures, and can cover large areas including ulcers and tumors, according to an FDA release. “We are extremely pleased to receive this approval to market from FDA. We have worked diligently to bring ...
Source: Mass Device - May 8, 2018 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Endoscopic / Arthroscopic Food & Drug Administration (FDA) Regulatory/Compliance Cook Medical Source Type: news
Applied Medical touts surgical GI wound protector study data
Applied Medical this week released results from a meta-analysis study of wound protectors used during lower gastro intestinal procedures, touting their ability to reduce surgical site infections. Results from the study were published this month in the journal Surgical Endoscopy, the Rancho Santa Margarita, Calif.-based company said. Data from the analysis, which examined 12 randomized controlled trials with 3,029 participants, indicated that use of wound protectors like the company’s Alexis system significantly reduced rates of SSI patients undergoing lower GI surgery. Furthermore, SSI rates were reduced by 63% when ...
Source: Mass Device - March 30, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Surgical Applied Medical Resources Corp. Source Type: news
Urgent Endoscopy Predicts Lower Death Rate in UGIB (CME/CE)
(MedPage Today) -- But did not impact rebleeding rate in high-risk acute nonvariceal upper GI bleeding (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - March 21, 2018 Category: Gastroenterology Source Type: news
March Madness: Boston Scientific Continues Buying Spree
Boston Scientific is set to acquire NxThera, a urology specialist, for about $406 million. The transaction consists of an upfront cash payment of $306 million, and up to an additional $100 million in potential commercial milestone payments over the next four years. The deal is set to close in the second quarter of 2018. Maple Grove, MN-based NxThera has developed and commercialized the Rezūm system, which is a minimally invasive therapy for the treatment of symptoms arising from benign prostatic hyperplasia (BPH). The system was cleared by FDA in 2015 and has CE mark. Treatment with the Rezūm system is typicall...
Source: MDDI - March 21, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news
The joy of cooking (and eating) after tracheomalacia
For most little kids, a trip to the supermarket is an annoying chore, made tolerable only by the opportunity to request sugary snacks as a reward. But when Charlotte McQueen accompanies her mother, Erin, to the store, it’s a journey marked by imagination and delight. “Mom, can we get that?” she asks, pointing to a can of pureed pumpkin. “Oh, and we’ll need marshmallows and we can make chocolate frosting. It will be a great cake!” At nearly 5 years old, Charlotte is an avid baker — a talent she picked up not at culinary school, but at the Yawkey Family Inn. There, a volunteer taught...
Source: Thrive, Children's Hospital Boston - January 10, 2018 Category: Pediatrics Authors: Jessica Cerretani Tags: Diseases & Conditions Our Patients’ Stories Dori Gallagher Dr. Michael Manfredi Dr. Russell Jennings Esophageal and Airway Treatment Center esophageal atresia and tracheoesophageal fistula posterior tracheopexy tracheomalacia Yawkey Fa Source Type: news
7 medtech stories we missed this week: Aug. 18, 2017
[Image from unsplash.com]From Nemaura’s new Oceania distribution deal to Sanuwave’s promissory note expansion, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Nemaura inks Oceania distribution deal for SugarBeat patch Nemaura announced in an Aug. 15 press release that it has signed a non-binding distribution deal with Device Technologies for exclusive rights to market the SugarBeat glucose monitoring system in Australia and New Zealand. The SugarBeat is a disposable, adhesive skin patch that is used by diabetics, providing a non-invasive and needle-free method of c...
Source: Mass Device - August 18, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Diabetes Diagnostics Implants Orthopedics Research & Development Surgical Brenner Medical Clinical Innovations Device Technologies K2M Masimo MedTech Nemaura Medical Sanuwave Si-Bone Source Type: news
Less-invasive Surgery Better for Very High-risk Patients With Necrotizing Pancreatitis Less-invasive Surgery Better for Very High-risk Patients With Necrotizing Pancreatitis
In the highest-risk patients with necrotizing pancreatitis, endoscopic and minimally invasive surgical necrosectomy are associated with lower mortality risk than open necrosectomy, according to data pooled from 15 cohorts in eight countries.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 16, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news
7 medtech stories we missed this week: June 23, 2017
[Image from unsplash.com]From Guardant suing Foundation Medicine to Interson receiving 510(k) clearance for ultrasound probes, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Guardant levels false advertising suit against Foundation Medicine Guardant Health announced in a June 22 press release that it has filed a lawsuit against Foundation Medicine for false advertising and unfair competition. Guardant Health is claiming that Foundation Medicine’s advertising causes harm to Guardant Health and its patients because it misleads oncologists about the sensitivity and accuracy of...
Source: Mass Device - June 23, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Business/Financial News Clinical Trials Food & Drug Administration (FDA) Implants Neurological Regulatory/Compliance Ultrasound EndoStim Foundation Medicine Inc. Guardant Health Interson Lee's Pharmaceutical Meditech Med Source Type: news
Challenging tradition: Can appendicitis be treated solely with medication?
For 130 years, surgery has been the standard treatment for appendicitis — inflammation of the appendix, a short tube extending from the colon.After all, it ’s best to remove an infected body part that is not essential to survival rather than risk a rupture that spews bacteria into the abdomen. Right? Maybe not.UCLADr. David TalanDr. David Talan, professor in the department of emergency medicine at the David Geffen School of Medicine at UCLA, is helping to lead a $12-millionclinical trial to determine whether treating appendicitis solely with antibiotics can be a safe, effective and less expensive alternative to...
Source: UCLA Newsroom: Health Sciences - March 9, 2017 Category: Universities & Medical Training Source Type: news
Even Without PPI, Oozing Peptic Ulcers Rarely Rebleed After Endoscopic Hemostasis Even Without PPI, Oozing Peptic Ulcers Rarely Rebleed After Endoscopic Hemostasis
The rebleeding rate of oozing peptic ulcer bleeds (PUB) after successful endoscopic therapy is low, and 72 hours of IV proton pump inhibitor (PPI) does not lower the rate further, according to results of a large multinational randomized trial.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - February 16, 2017 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
Creo Medical looks to raise $25m in UK IPO
U.K.-based electrosurgery device developer Creo Medical said today it looks to raise $25.3 million (UK £20 million) in a U.K. initial public offering, expected to take place on December 9. Creo Medical said it plans to offer shares at approximately 97¢ per share (UK £0.79), while the company has an estimated market capitalization of approximately $77.7 million (UK £61.3 million). The company is developing minimally invasive surgical devices, initially focused on gastrointestinal surgery and lung cancer, using the company’s Croma system which combines bipolar radiofrequency and microwave en...
Source: Mass Device - December 6, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Initial Public Offering (IPO) Surgical Creo Medical Source Type: news
For malignant biliary obstruction, plastic stents may be cost-effective alternative
(American Society for Gastrointestinal Endoscopy) Preoperative biliary drainage (PBD) with stent placement has been commonly used for patients with malignant biliary obstruction. In PBD, the placement of fully covered self-expandable metal stents may provide better patency duration and a lower incidence of cholangitis compared with plastic stents. But a new study in the November issue of GIE: Gastrointestinal Endoscopy suggests that plastic stents may provide similar outcomes at a potential cost savings. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 3, 2016 Category: Global & Universal Source Type: news
How Common are Herniated Disks in Children?
Discussion Intervertebral disk herniation occurs at the same locations in pediatric patients as adults with L4-L5 and L5-S1 being the most common. Patients often (30-60% for lumbar disk patients) have a direct trauma or sports related injury that is identified before the onset of pain. There is also a group of morbidly obese patients who probably have degenerative disease. In adults and children, lumbar disk herniation is also seen with repetitive or excessive axial loading, poor conditioning, decreased range of motion and history of prior back injury. Disk herniation is caused by vertebral motion that causes increased int...
Source: PediatricEducation.org - September 19, 2016 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
Incidence of cancer in patients with large colorectal polyps lower than previously thought
For the majority of patients with large or difficult to remove colorectal polyps (growths in the colon), the incidence of cancer is actually lower than previously thought, and using more advanced endoscopic techniques that spare the colon may be a better, safer alternative to a traditional operation in certain cases, according to study results. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 30, 2016 Category: Science Source Type: news
Incidence of cancer in patients with large colorectal polyps lower than previously thought
(American College of Surgeons) For the majority of patients with large or difficult to remove colorectal polyps (growths in the colon), the incidence of cancer is actually lower than previously thought, and using more advanced endoscopic techniques that spare the colon may be a better, safer alternative to a traditional operation in certain cases, according to study results published online in the Journal of the American College of Surgeons in advance of print publication. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 30, 2016 Category: Cancer & Oncology Source Type: news
Olympus slides on profit outlook despite swing to Q4, 2016 black
Shares in Olympus (TYO:7733) slid as much as -6.9% today before closing down -4.6% at roughly $33.67 (¥4,010.00), after the Japanese tech conglomerate said it expects lower sales and profits during its fiscal year ending next March. Olympus said it expects sales to be off by -0.6% at about $7.46 billion (¥800 billion) for fiscal 2017. Operating profits could slide as much as -14% to $756 million (¥90 billion) due to the strong yen, the company said. Earlier this week, Olympus said it swung to black for the 3 months and full year ended March 31, 2016. Profits were $165.8 million (¥19.74 billion) on...
Source: Mass Device - May 6, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Endoscopic / Arthroscopic MassDevice Earnings Roundup Wall Street Beat Olympus Source Type: news
St. Jude Medical’s Axium chronic pain device makes its U.S. debut
St. Jude Medical (NYSE:STJ) today announced the U.S. debut of its Axium neurostimulator system, after the device won FDA approval in February for treating chronic pain. The 1st patients were implanted in West Virginia and California with the Axium device, which uses dorsal root ganglion stimulation to treat moderate to severe chronic intractable pain of the lower limbs in adult patients with complex regional pain syndrome, St. Jude said. The Axium is slated to be implanted in 25 states in the coming weeks, with 100 procedures due in the 1st month after launch, the Little Canada,...
Source: Mass Device - April 11, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Neuromodulation/Neurostimulation Pain Management Wall Street Beat St. Jude Medical Source Type: news
Verb Surgical CEO Heunnekens says company is focusing on “digital surgery”
Verily and Johnson & Johnson‘s (NYSE:JNJ) collaborative business Verb Surgical looks to set the stage for a new style of robotic surgery, called “digital surgery,” according to an interview with CEO Scott Huennekens. Verb Surgical aims to develop a comprehensive surgical platform that incorporates “leading edge” robotic capabilities and medical technology for use in the operating room, according to Johnson & Johnson. The company plans to develop them in partnership with surgeons and hospitals with a goal of “greater hospital efficiency.” “First of all, we th...
Source: Mass Device - April 4, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Research & Development Robot-Assisted Surgery Robotics Surgical Intuitive Surgical Inc. Johnson & Johnson Verb Surgical Verily Source Type: news
Solving the 5,000-Year-Old Murder of Otzi the Iceman
In 1991, the mummified body of a 5,000-year-old murder victim was discovered in melting ice at a rock-gully crime scene high in the Italian Otzal Alps. Nicknamed "Otzi", the estimated 45-year-old man and his possessions were incredibly well preserved. His skin, hair, bones, and organs were cryopreserved in time, allowing archeological researchers a phenomenal insight into human life in the Copper Age. The frozen corpse also gave modern science the opportunity to forensically investigate and positively determine how Otzi the Iceman was killed. The story began on a sunny September day, when two hikers were traversi...
Source: Science - The Huffington Post - February 11, 2016 Category: Science Source Type: news
Five predictions for medtech in 2016
by Brian Chapman The holidays are the perfect time for reflection. It’s time to think about the year and the accomplishments of the past, and especially to contemplate the future. It’s in this spirit that I want to offer my five predictions for medtech in 2016. Tech Companies Will Rise to Prominence in Healthcare Reading the press, this might not seem like such a controversial prediction. Every day there’s another article about Apple, Google, Philips, Fitbit—tech companies large and small flocking to apply their disruptive mindsets and agile creativity to the musty establishment of old-world hea...
Source: Mass Device - December 17, 2015 Category: Medical Equipment Authors: MassDevice Tags: Blog Source Type: news
Medtronic touts study of accuracy, cost effectiveness of capnography monitors
Medtronic (NYSE:MDT) today presented data from 2 clinical studies of its capnography patient monitoring systems, touting their accuracy and cost-effectiveness. Data from the studies was presented at the Anesthesiology 2015 annual meeting in San Diego this week. “The findings presented today demonstrate the clinical benefits and potential cost savings capnography can provide across a broad spectrum of patients. These studies underscore Medtronic’s commitment to reducing the growing burden of respiratory compromise across clinical settings to improve the health and care of patients,” Medtronic mi...
Source: Mass Device - October 28, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Diagnostics Medtronic Source Type: news
Boston Scientific launches Captivator EMR device
Boston Scientific (NYSE:BSX) said today it launched the Captivator endoscopic mucosal resection device designed as a minimally-invasive alternative to esophagectomy procedures. The Captivator allows for staging and removal of precancerous tissue and early esophageal cancer in the upper gastrointestinal tract, the Marlborough, Mass.-based company said. The device gives operating physicians a 360 degree view of the esophagus and can be used with accessory devices that can be used to “manage potential complications quickly,” the company said. “The Captivator EMR Device provides improved e...
Source: Mass Device - September 29, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Endoscopic / Arthroscopic Otolaryngology Ear, Nose & Throat Surgical Boston Scientific Source Type: news
Marissa’s story: “Esophageal atresia is never going to define me”
Marissa Waite lives in the smallest town in Massachusetts, but she has a big story to tell. When her mother Vicky was pregnant with Marissa 13 years ago, an ultrasound detected esophageal atresia (EA), a condition where the esophagus isn’t connected to the stomach. Vicky was admitted to Brigham and Women’s Hospital for the remainder of her pregnancy. “I’m a take-charge kind of person. When I was pregnant, I thought, ‘I’ll make all the decisions for my baby.’ But when complications arose, I realized I couldn’t make these kinds of decisions alone,” she says. At that point...
Source: Thrive, Children's Hospital Boston - August 13, 2015 Category: Pediatrics Authors: Jenny Fernandez Tags: All posts Our patients’ stories esophageal atresia GERD Steven Fishman VSD Wayne Tworetzky Source Type: news
MassDevice.com +3 | The top 3 medtech stories for July 15, 2015
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. 3. Gore asks U.S. Supreme Court to revisit $1B loss to Bard W.L. Gore & Associates asked the U.S. Supreme Court to revisit its $1 billion infringement loss to C.R. Bard over stent graft patents, saying the high court should determine whether patents must be conveyed in writing. Gore is on the...
Source: Mass Device - July 15, 2015 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 3 Source Type: news
Lower-cost procedure for children with digestive tract problems
Physicians have published research that suggests a safe and lower-cost way to diagnose and treat problems in the upper gastrointestinal tract of children. The researchers assessed the effectiveness of unsedated transnasal endoscopy (TNE) in evaluating pediatric patients with potentially chronic problems in their esophagus, which is the tube that connects the patient's mouth to the stomach. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 15, 2015 Category: Science Source Type: news
Retaliation claims stand in ex-rep’s suit against ConMed
The retaliation claim leveled against ConMed (NSDQ:CNMD) by a former sales rep who accused the company of firing him because he’s Iranian-American can stand, a federal appeals court ruled yesterday, but found that a lower court’s dismissal of a discrimination claim can also stay on the books. Reza Yasdian was a territory manager for ConMed’s endoscope business in Cincinnati from April 2005 until he was fired in July 2010, according to court documents filed with the 6th Circuit Court of Appeals. “By all accounts, Yazdian was a talented salesman, receiving awards, bonuses, and promotions for his ...
Source: Mass Device - July 15, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Legal News ConMed Corp. Personnel Source Type: news
Fewer People Are Sensitive To Gluten Than Commonly Believed
By Julie Upton for U.S. News It seems as if everyone is going to great lengths to avoid gluten, a protein found in wheat, barley, rye and many processed foods. Are there real health benefits associated with going gluten-free, or is it just another passing fad? A recently published study in the journal Digestion found that 86 percent of individuals who believed they were gluten sensitive could tolerate it. Individuals with celiac disease, a hereditary autoimmune condition that affects about 3 million Americans, or roughly 1 percent of the population, must avoid gluten. Those with extremely rare wheat allergies must also r...
Source: Healthy Living - The Huffington Post - June 21, 2015 Category: Consumer Health News Source Type: news
Was The Guardian's 2014 crystal ball accurate?
In January 2014, The Guardian took the brave, and possibly foolhardy, step of predicting the six big health breakthroughs of 2014. We're taking a look at just how accurate the paper's crystal ball turned out to be, and gave each our own Behind the Headlines "Mystic Meg" rating for predictive accuracy. Prediction one: IVF success rates to improve after 20 years of stagnation Prediction two: Better screening for ovarian cancer Prediction three: New insights into dementia Prediction four: Open-access surgery Prediction five: Ninja polymers to fight athlete's foot Prediction six: Faecal ...
Source: NHS News Feed - December 30, 2014 Category: Consumer Health News Tags: QA articles Special reports Source Type: news
To heal the human instrument
When Erik Laurence transferred in 2009 to Shanghai, China, as vice president of a software company, he thought his biggest challenge would be improving his Mandarin-language skills and learning the nuances of the Chinese business scene. But his vocal cords, not the foreign nation, turned out to be his undoing. Laurence, who was in his mid-40s at the time, had struggled for about 20 years with a mild case of spasmodic dysphonia (SD), intermittently losing his voice at odd times. It’s a neurological disorder that involves spasms of the vocal cords, which cause the voice to break up or have a strained or strangled ...
Source: UCLA Newsroom: Health Sciences - November 21, 2014 Category: Universities & Medical Training Source Type: news
SEDASYS Computer-Assisted Propofol Sedation System Rolling Out in U.S.
SEDASYS, a division of Ethicon, itself part of J&J, is releasing the SEDASYS Computer-Assisted Personalized Sedation (CAPS) System in the U.S. market. The device is intended for delivery of propofol (1% (10 mg/mL) injectable emulsion) by non-anesthesiologist clinicians when performing colonoscopy and esophagogastroduodenoscopy procedures. The technology allows administration of minimal to moderate amounts of propofol during upper and lower GI endoscopies and for monitoring of patient sedation. According to the company, only adult ASA class I and II patients are eligible to receive propofol via SEDASYS. The SEDASYS...
Source: Medgadget Anesthesiology - October 14, 2014 Category: Anesthesiology Authors: Editors Tags: Anesthesiology GI Source Type: news
What Factors Decide Urolithiasis Treatment?
Discussion Although pediatric uroliathiasis is relatively rare, there has been an increasing number of children evaluated for renal stones over time. For an overview of uroliathiasis click here. Renal colic classically has paroxysmal pain that is severe, radiates toward the groin and the patient is not able to find a comfortable position. They may also have irritability, nausea, emesis, increased urinary frequency, dysuria and hematuria. 85-90% of patients will have macro- or microscopic hematuria but up to 15% of patients with urolithiasis will not have hematuria. Clinical differential diagnosis includes but is not limit...
Source: PediatricEducation.org - October 13, 2014 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
Highlights from the June issue of GIE: Gastrointestinal Endoscopy
(American Society for Gastrointestinal Endoscopy) The June issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy, features a study reporting that the annual incidence rate of esophageal cancer among patients with Barrett's esophagus with low-grade dysplasia is 0.54 percent; a study showing that metabolic syndrome and smoking heighten concerns regarding colorectal cancer screening in men with these risk factors; and a new ASGE guideline on endoscopy in patients with lower gastrointestinal bleeding. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 23, 2014 Category: Global & Universal Source Type: news
FDA downgrades Given Imaging's PillCam
FDA medical device regulators put a lower-risk label on Covidien subsidiary Given Imaging's PillCam ingestible endoscopic camera. Covidien (NYSE:COV) subsidiary Given Imaging landed a victory with FDA medical device regulators who agreed to downgrade the PillCam capsule endoscope to a lower-risk classification. Covidien, Food & Drug Administration (FDA), Given ImagingNews Well, 510(k), Endoscopic / Arthroscopic, Food & Drug Administration (FDA), Imaging, Regulatory/Complianceread more (Source: Mass Device)
Source: Mass Device - May 16, 2014 Category: Medical Equipment Authors: Arezu Sarvestani Source Type: news
Meta-Analysis on Lower-GI Endoscopy Offers Reassurance, But Not Resolution (FREE)
By Joe Elia Evidence that screening with either sigmoidoscopy or colonoscopy greatly reduces overall risks for colorectal cancer is "compelling and consistent," according to a BMJ meta-analysis. However, choosing between … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - April 14, 2014 Category: Primary Care Source Type: news
Gastric balloon pill launched in UK
Most of the UK media has got rather overexcited about the UK launch of Obalon, a gastric balloon in pill form that can be swallowed to help overweight people achieve rapid weight loss without invasive surgery. The Obalon pills are designed to be inflated into balloons in the stomach, reducing the free volume of the stomach and therefore how much a person can eat before they feel full. Intra-gastric balloons are not new, and are sometimes provided to extremely obese people through the NHS, although these often have to be surgically implanted. Obalon has been approved in Europe for overweight and obese adults, but in th...
Source: NHS News Feed - January 22, 2014 Category: Consumer Health News Tags: Medical practice Obesity QA articles Source Type: news
The Behind the Headlines 2013's Top Five of Top Fives
As we move towards the end of the year, like all news sources, we fall back on that classic space filler – the list story. So without further ado, here is the official Behind the Headlines Top Five of Top Fives stories of 2013. The top five "Good work team!" stories of the year We can often get bogged down in pointing out dodgy sub-group analyses, spurious extrapolations of samples sizes containing just four men and a dog, and RCTs pointing out the benefits of chocolate on blood pressure that turned out to be funded by a chocolate-making conglomerate. So it's important not to lose sight of the fact t...
Source: NHS News Feed - December 31, 2013 Category: Consumer Health News Tags: QA articles Medical practice Source Type: news
“Long-Term Colorectal Cancer Incidence and Mortality after Lower Endoscopy”,
Colonoscopy and sigmoidoscopy have been shown to provide protection against colorectal cancer, but the magnitude and duration of protection, particularly against proximal colon cancer, remain undefined. A study of long-term colorectal cancer incidence and mortality after lower endoscopy reported in The New England Journal of Medicine by Reiko Nishihara, PhD, of Dana-Farber Cancer Institute and Harvard Medical School, and colleagues found that both colonoscopy and sigmoidoscopy for any indication... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - November 15, 2013 Category: Cancer & Oncology Source Type: news
Tight belts are unlikely to give you throat cancer
Conclusion This was a small, short-term, and highly technical study which measured certain changes in the junction of the oesophagus and stomach in volunteers, half of whom were obese. It found that wearing a weight-lifter’s belt and a greater waist circumference was associated with changes in the lining of the oesophagus at the junction between the oesophagus and the stomach. These changes are associated with an increased risk of cancer, but the researchers did not set out to find if belts or obesity caused cancer. The researchers also found that volunteers wearing a waist belt had more signs of acid reflux in thi...
Source: NHS News Feed - October 2, 2013 Category: Consumer Health News Tags: Cancer Source Type: news
Dolly Parton: Suffering From GERD Faces Esophageal Cancer Scare
There have been reports that Dolly Parton has had surgery to treat her acid reflux disease because of a fear of developing esophageal cancer. It is reported that even though Dolly Parton has suffered from gastroesophageal reflux disease for several years, it was because she had a dramatic weight loss that the fear she had developed esophageal cancer crept in. A source reported the laparoscopic surgery was performed on June 4th to implant a device called a LINX. This device consists of a series of titanium beads, each with a magnetic core, connected together with titanium wires to form a ring shape. It is implanted around ...
Source: About Heartburn / Acid Reflux - July 30, 2013 Category: Consumer Health News Source Type: news
How Common Are Gastric Ulcers?
Discussion The exact cause of gastric and upper intestinal inflammation and ulceration are not entirely understood. Imbalances between irritative factors and mucosal defenses underlie it. Gastric acid production is at adult levels by 3-4 years. Actual ulceration is associated with a lower acid secretion for gastric ulcerations but are increased in duodenal ulcerations in both adults and children. In adults changes to the mucus layer of the stomach and duodenum and bicarbonate secretion play a part in upper GI inflammation and ulcerations. Genetic studies have been linked to differences in both acid production, and mucosal ...
Source: PediatricEducation.org - July 1, 2013 Category: Pediatrics Authors: Donna M. D'Alessandro, M.D. Tags: Uncategorized Source Type: news
New alternative to surgery lets doctors remove suspicious polyps, keep colon intact
Millions of people each year have polyps successfully removed during colonoscopies. But when a suspicious polyp is bigger than a marble or in a hard-to-reach location, patients are referred for surgery to remove a portion of their colon — even if doctors aren't sure whether the polyp is cancerous or not. Since only 15 percent of all polyps turn out to be malignant, many patients are unnecessarily subjected to the risks of this major surgery. Now there is an alternative. A UCLA team of surgeons and gastroenterologists has been performing a new, minimally invasive procedure to remove large and hard-...
Source: UCLA Newsroom: Health Sciences - June 17, 2013 Category: Universities & Medical Training Source Type: news
SEDASYS Propofol Sedation System Gets FDA Nod
Ethicon Endo-Surgery, a Johnson & Johnson company, announced that the FDA granted PMA approval for its SEDASYS device, the first computer-assisted personalized sedation (CAPS) system for use by clinicians in the endoscopy suites.In other words, the system aims to replace anesthesiologists and CRNAs with computerized technology to administer propofol and to monitor minimal-to-moderate sedation in patients undergoing upper and lower endoscopies. According to the company, only ASA class I and II patients are eligible to receive propofol via SEDASYS.Read More (Source: Medgadget Anesthesiology)
Source: Medgadget Anesthesiology - May 10, 2013 Category: Anesthesiology Authors: Editors Tags: Anesthesiology GI Source Type: news
UCLA study shows promise, offers hope for brain hemorrhage patients
A new endoscopic surgical procedure has been shown to be safer and to result in better outcomes than the current standard medical treatment for patients who suffer strokes as a result of brain hemorrhages, UCLA neurosurgeons have announced. The findings from their potentially groundbreaking, randomized, controlled phase 2 clinical trial, which was conducted at multiple medical centers, were presented last week at the International Stroke Conference in Honolulu. "These exciting results offer a glimmer of hope for a condition that most doctors have traditionally considered hopeless," said principal in...
Source: UCLA Newsroom: Health Sciences - February 11, 2013 Category: Universities & Medical Training Source Type: news
Simple Education Program Substantially Increases Detection Of Easy-To-Miss Precancerous Polyps
Most people know a colonoscopy requires some preparation by the patient. Now, a Mayo Clinic physician suggests an additional step to lower the risk of colorectal cancer: Ask for your doctor's success rate detecting easy-to-miss polyps called adenomas. The measure of success is called the adenoma detection rate, or ADR, and has been linked to a reduced risk of developing a new cancer after the colonoscopy. The current recommended national benchmark is at least 20 percent, which means that an endoscopist should be able to detect adenomas in at least 1 of 5 patients getting a colonoscopy... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 10, 2013 Category: Consumer Health News Tags: Colorectal Cancer Source Type: news
Analysis bolsters expulsive therapy's cost-effectiveness
Patients who receive medical expulsive therapy as initial management for renal colic incur significantly lower episode-related expenditures than those undergoing early endoscopic stone removal, but are significantly more likely to have return visits to the emergency department, report researchers from the University of Michigan, Ann Arbor. (Source: Modern Medicine)
Source: Modern Medicine - January 1, 2013 Category: Journals (General) Source Type: news